Alerislife has roughly 66.99
M in cash with (7.57
M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.84, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Alerislife has an asset utilization ratio of 248.38 percent. This connotes that the company is making $2.48 for each dollar of assets. An increasing asset utilization means that Alerislife is more efficient with each dollar of assets it utilizes for everyday operations.
How important is Alerislife's Liquidity
Alerislife
financial leverage refers to using borrowed capital as a funding source to finance Alerislife ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Alerislife financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Alerislife's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Alerislife's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Alerislife's total debt and its cash.
Alerislife Correlation with Peers
Investors in Alerislife can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in Alerislife. Diversification will allow for the same portfolio return with reduced risk. The correlation table of Alerislife and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities Alerislife is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with
your current brokerage. Please check
volatility of Alerislife for more details
An Additional Perspective On Alerislife
Alerislife is abnormally volatile given 3 months investment horizon.
Alerislife secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had 0.13% of return per unit of standard deviation over the last 3 months. Our philosophy in foreseeing the risk of a stock is to use both market data as well as company specific technical data. We were able to break down and interpolate twenty-one different
technical indicators, which can help you to evaluate if expected returns of 1.13% are justified by taking the suggested risk. Use Alerislife
risk adjusted performance of 0.1216, and Mean Deviation of 3.77 to evaluate company specific risk that cannot be
diversified away.
Alerislife is projected to stay under USD1.34 in March
Standard deviation is down to 8.71. It may connote a possible volatility fall.
As of the 25th of February, Alerislife shows the
mean deviation of 3.77, and Risk Adjusted Performance of 0.1216. Alerislife
technical analysis gives you the methodology to make use of
historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of
historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate nineteen
technical drivers for Alerislife, which can be compared to its rivals. Please confirm
Alerislife standard deviation, as well as the
relationship between the maximum drawdown and
expected short fall to decide if Alerislife is priced correctly, providing market reflects its regular price of 1.31 per share. Given that Alerislife is a hitting penny stock territory we recommend to closely look at its
total risk alpha.
Our Final Take On Alerislife
While some other companies within the medical care facilities industry are still a little expensive, even after the recent corrections, Alerislife may offer a potential longer-term growth to retail investors. While some retail investors may not share our view, we believe that right now is not a good time to increase your holdings in Alerislife. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Alerislife.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Ellen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Alerislife. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
[email protected]
